Record year for Alzheimer’s Research

Alzheimer’s Research UK has announced a record-breaking year with its total income reaching £38.5 million in 2018/19.

The growth in income for the year was fuelled by a rise in public support, with voluntary donations reaching £36.7m.

Across the year, the organisation committed £25m to its charitable activities, including £19.8m towards pioneering research.

In 2018/19, it supported 88 research projects across the year focusing on all forms of dementia, with the charity’s researchers making more than 200 new discoveries about the diseases that drive dementia.

Scientists at its Drug Discovery Alliance progressed their drug discovery portfolio to include 21 potential new treatments in development across the three landmark Drug Discovery Institutes.

Hilary Evans, chief executive of Alzheimer’s Research UK, said: “This has been an incredible year for Alzheimer’s Research UK, and we’re delighted to achieve so much thanks to the amazing people who continue to support our cause. It’s hugely encouraging to see more people joining us in our mission to bring about the first life-changing treatment for dementia.

She added: “But this growth in support also underlines a heartbreaking truth: that one in two of us know someone affected by dementia, which is now the health crisis of our time. There is much more to do to achieve our mission, but we know that with our fantastic supporters, we will make breakthroughs possible.”

The charity also worked to change the conversation about dementia, reaching over 14m people with Make Breakthroughs Possible, an awareness campaign that emphasised the hope that lies in research.

TFN is published by the Scottish Council for Voluntary Organisations, Mansfield Traquair Centre, 15 Mansfield Place, Edinburgh, EH3 6BB. The Scottish Council for Voluntary Organisations (SCVO) is a Scottish Charitable Incorporated Organisation. Registration number SC003558.